Business

MGC Receive Permission for Psilocybin Research & Development

MGC Receive Permission for Psilocybin Research & Development

Argent Biopharma LtdApril 2, 20233
MGC Receive Permission for Psilocybin Research & Development

About this update from Argent Biopharma Ltd

Argent Biopharma Limited has released a press release. View Attachment

View stock analysis, news, and events for Argent Biopharma Ltd

More from Argent Biopharma Ltd

All Argent Biopharma Ltd news →